Jonathan Yong
Stock Analyst at UBS
(2.66)
# 1,955
Out of 4,829 analysts
104
Total ratings
60%
Success rate
10.49%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Maintains: Neutral | $9.5 → $7 | $5.12 | +36.72% | 5 | May 8, 2025 | |
| CLOV Clover Health Investments | Initiates: Neutral | $4 | $3.51 | +13.96% | 3 | Oct 7, 2024 | |
| OSCR Oscar Health | Initiates: Neutral | $23 | $17.11 | +34.42% | 7 | Oct 7, 2024 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $23.07 | +8.37% | 2 | Aug 24, 2023 | |
| WBA Walgreens Boots Alliance | Maintains: Neutral | $33 → $30 | $11.22 | +167.38% | 5 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $10.28 | +16.73% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $4.32 | +85.19% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $14.01 | +85.58% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $51.96 | -73.06% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $68.64 | +39.86% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $32 | $14.92 | +114.48% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $22.00 | +377.27% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $116.41 | -31.28% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $245.73 | -5.99% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $95.30 | +5.98% | 5 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $7.11 | +279.75% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $148.22 | -32.53% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $693.46 | -35.11% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $3.69 | +225.20% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $6.84 | +923.39% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $14.27 | +19.13% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $322.20 | +8.63% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $23.84 | +298.49% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $8.20 | +3.66% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $25.02 | +63.87% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $7.01 | +142.51% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.50 | +142.86% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $75.87 | +12.03% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $176.96 | -17.50% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $62.79 | +68.82% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $181.78 | -13.63% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $333.46 | +10.36% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $249.53 | +154.48% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $66.97 | +74.71% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $14.53 | +106.47% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $353.70 | -15.75% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $148.83 | -36.17% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $380.64 | +30.04% | 1 | Oct 15, 2021 |
eHealth
May 8, 2025
Maintains: Neutral
Price Target: $9.5 → $7
Current: $5.12
Upside: +36.72%
Clover Health Investments
Oct 7, 2024
Initiates: Neutral
Price Target: $4
Current: $3.51
Upside: +13.96%
Oscar Health
Oct 7, 2024
Initiates: Neutral
Price Target: $23
Current: $17.11
Upside: +34.42%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $23.07
Upside: +8.37%
Walgreens Boots Alliance
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $30
Current: $11.22
Upside: +167.38%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $10.28
Upside: +16.73%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $4.32
Upside: +85.19%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $14.01
Upside: +85.58%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $51.96
Upside: -73.06%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $68.64
Upside: +39.86%
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $14.92
Upside: +114.48%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $22.00
Upside: +377.27%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $116.41
Upside: -31.28%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $245.73
Upside: -5.99%
Jul 27, 2023
Reiterates: Neutral
Price Target: $101
Current: $95.30
Upside: +5.98%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $7.11
Upside: +279.75%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $148.22
Upside: -32.53%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $693.46
Upside: -35.11%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $3.69
Upside: +225.20%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $6.84
Upside: +923.39%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $14.27
Upside: +19.13%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $322.20
Upside: +8.63%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $23.84
Upside: +298.49%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $8.20
Upside: +3.66%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $25.02
Upside: +63.87%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $7.01
Upside: +142.51%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.50
Upside: +142.86%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $75.87
Upside: +12.03%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $176.96
Upside: -17.50%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $62.79
Upside: +68.82%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $181.78
Upside: -13.63%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $333.46
Upside: +10.36%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $249.53
Upside: +154.48%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $66.97
Upside: +74.71%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $14.53
Upside: +106.47%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $353.70
Upside: -15.75%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $148.83
Upside: -36.17%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $380.64
Upside: +30.04%